公司名稱: 格林國際控股有限公司 呈交日期: 2026年1月5日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02700 | 說明 | N/A | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,000,000,000 | HKD | | 0.2 | HKD | | 200,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 1,000,000,000 | HKD | | 0.2 | HKD | | 200,000,000 | 本月底法定/註冊股本總額： HKD 200,000,000 FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 格林國際控股有限公司 呈交日期: 2025年12月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02700 | 說明 | N/A | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,000,000,000 | HKD | | 0.2 | HKD | | 200,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 1,000,000,000 | HKD | | | 0.2 HKD | | 200,000,000 | 本月底法 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 格林國際控股有限公司 呈交日期: 2025年11月5日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02700 | 說明 | N/A | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,000,000,000 | HKD | | 0.2 | HKD | | 200,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 1,000,000,000 | HKD | | 0.2 | HKD | | 200,000,000 | 本月底法 ...

截至月份: 2025年9月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 格林國際控股有限公司 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 呈交日期: 2025年10月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02700 | 說明 | N/A | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,000,000,000 | HKD | | 0.2 | HKD | | 200,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 1,000,000,000 | HKD | | 0.2 | HKD | | 200,000,000 | 本月底法定 ...

GREEN INTERNATIONAL HOLDINGS LIMITED 格林國際控股有限公司 (Incorporated in the Cayman Islands with limited liability) （於開曼群島註冊成立之有限公司） (Stock Code 股份代號：2700) NOTIFICATION LETTER 通知信函 Dear Non-Registered Holder(Note 1), 30 September 2025 GREEN INTERNATIONAL HOLDINGS LIMITED (the "Company") The English and Chinese versions of the Company's Current Corporate Communications are available on the Company's website at http://www.irasia.com/listco/hk/greeninternational/ and the website of The Stock Exchange of Hong Kong Limi ...

GREEN INTERNATIONAL HOLDINGS LIMITED 格林國際控股有限公司 (Incorporated in the Cayman Islands with limited liability) （於開曼群島註冊成立之有限公司） (Stock Code 股份代號：2700) NOTIFICATION LETTER 通知信函 30 September 2025 Dear Registered Shareholder, GREEN INTERNATIONAL HOLDINGS LIMITED (the "Company") Note: Corporate Communications include any document(s) issued or to be issued by the Company for the information or action of holders of any of its securities or the investing public, including but not limited to (a) the directors' report ...

Financial Performance - Revenue for the six months ended June 30, 2025, was HKD 28,176,000, representing a 8.7% increase from HKD 25,921,000 in the same period of 2024[8] - Gross profit increased to HKD 19,280,000, up 37.5% from HKD 14,034,000 year-on-year[8] - The company reported a net loss of HKD 2,385,000 for the period, compared to a net loss of HKD 1,609,000 in 2024, indicating a deterioration in performance[9] - Basic and diluted loss per share was HKD 0.53, compared to HKD 0.23 in the previous year, reflecting a 130.4% increase in loss per share[8] - The total comprehensive loss for the period ended June 30, 2025, was HKD 3,526,000, compared to a loss of HKD 1,522,000 for the same period in 2024, representing an increase in loss of approximately 131.5%[15] - The group reported a loss before tax of HKD 2,575,000 for the six months ended June 30, 2025, compared to a loss of HKD 1,681,000 for the same period in 2024, indicating a deterioration in performance[43] Assets and Liabilities - Total assets decreased to HKD 107,363,000 from HKD 113,445,000 as of December 31, 2024, a decline of 5.4%[12] - Non-current assets decreased from HKD 39,336,000 to HKD 34,012,000, a reduction of 13.5%[12] - Current assets slightly decreased to HKD 73,351,000 from HKD 74,109,000, a decline of 1.0%[12] - Total liabilities decreased to HKD 63,143,000 from HKD 67,766,000, a reduction of 6.9%[13] - The company reported a significant increase in bank borrowings, rising to HKD 4,199,000 from HKD 1,596,000, an increase of 162.5%[13] - As of June 30, 2025, total equity attributable to equity holders was HKD 39,266,000, down from HKD 41,164,000 as of January 1, 2024, reflecting a decrease of approximately 4.6%[15] Cash Flow - The net cash generated from operating activities for the six months ended June 30, 2025, was HKD 2,704,000, compared to HKD 3,089,000 for the same period in 2024, indicating a decline of about 12.5%[17] - The net cash used in investing activities for the six months ended June 30, 2025, was HKD 2,613,000, a significant decrease from the net cash generated of HKD 1,223,000 in 2024[17] - The net cash used in financing activities for the six months ended June 30, 2025, was HKD 2,054,000, an improvement compared to HKD 6,091,000 in the previous year, showing a reduction of approximately 66.3%[17] - As of June 30, 2025, cash and cash equivalents decreased to HKD 62,616,000 from HKD 63,463,000 at the beginning of the period, reflecting a decline of about 1.3%[17] Business Segments - For the six months ended June 30, 2025, the healthcare and medical business generated revenue of HKD 23,536,000, while the beauty and fitness business contributed HKD 4,640,000, totaling HKD 28,176,000[32] - The total net revenue for the six months ended June 30, 2025, was HKD 6,481,000, a significant increase from HKD 1,422,000 in the same period of 2024, representing a growth of approximately 355%[34] - The total non-current assets as of June 30, 2025, amounted to HKD 34,012,000, with HKD 33,784,000 attributed to the healthcare and medical business[37] Expenses and Cost Management - Direct costs and operating expenses decreased to approximately HKD 8,896,000, down about 25.16% from HKD 11,887,000 in 2024, primarily due to reduced product costs[69] - Administrative expenses were approximately HKD 10,083,000, a decrease of about 14.28% from HKD 11,763,000 in 2024, attributed to cost control measures[73] - The company incurred net financing costs of HKD 511,000 for the six months ended June 30, 2025, down from HKD 1,026,000 in 2024, indicating improved cost management[41] Shareholder Information - As of June 30, 2025, Mr. Liu Dong holds 25,146,000 shares (3.81%) and Ms. Zhou Cuiqiong holds 370,071,730 shares (56.08%) in the company[99] - Major shareholder Wei Xin International holds 370,071,730 shares (56.08%) and Chang Jian Limited holds 67,647,058 shares (10.25%) in the company[102] - The company confirmed compliance with the corporate governance code, with 370,071,730 shares held by Ms. Zhou and Wei Xin, representing approximately 56.1% of the total issued shares of 659,894,693 as of June 30, 2025[106] Governance and Compliance - The company has engaged an external consultant for internal audit functions due to the absence of an internal audit department, ensuring independent review of risk management and internal control systems[107] - The audit committee, consisting of three independent non-executive directors, has reviewed the unaudited consolidated financial statements, confirming compliance with applicable accounting standards and sufficient disclosure[109] - Mr. Cai Dawi resigned as an independent non-executive director effective June 26, 2025, leading to non-compliance with certain listing rules until a replacement is appointed[96] - Ms. Ma Sha was appointed as an independent non-executive director effective July 1, 2025, restoring compliance with listing rules regarding independent directors[97] Other Information - The company did not recommend any dividend for the six months ended June 30, 2025, consistent with the previous year[48] - The group has no significant investments as of June 30, 2025[84] - The group has not made any acquisitions or disposals of subsidiaries during the period[85] - The group employed 162 staff in Hong Kong and China as of June 30, 2025[94] - There are no significant ongoing or threatened litigations against the company or its subsidiaries as of the report date[95]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 格林國際控股有限公司 呈交日期: 2025年9月2日 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02700 | 說明 | | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | | 659,894,693 | | 0 | | 659,894,693 | | 增加 / 減少 (-) | | | | | | | | | | 本月底結存 | | | | 659,894,693 | | 0 | | 659,894,693 | 第 2 頁 共 10 頁 v 1.1.1 I. 法定/註冊股本變動 ...

Group 1 - The core viewpoint of the article is that Green International Holdings (02700.HK) reported an increase in revenue for the six months ending June 30, 2025, amounting to approximately HKD 28,176,000, which represents an increase of about 8.70% compared to the same period last year [1] - The company recorded a net loss of approximately HKD 2,385,000 during the period, compared to a net loss of HKD 1,609,000 in 2024 [1]

Core Viewpoint - Green International Holdings (02700) reported a mid-year performance for 2025, showing a revenue of HKD 28.176 million, which represents a year-on-year increase of 8.7%. However, the loss attributable to equity holders expanded to HKD 3.526 million, a year-on-year increase of 131.7%, with a basic loss per share of HKD 0.053 [1] Financial Performance - Revenue for the first half of 2025 reached HKD 28.176 million, marking an 8.7% increase compared to the previous year [1] - The loss attributable to equity holders was HKD 3.526 million, which is a significant increase of 131.7% year-on-year [1] - Basic loss per share was reported at HKD 0.053 [1]